TY - JOUR
T1 - Patient-Reported Outcome Measures in Food and Drug Allergy
AU - Anagnostou, Aikaterini
AU - Warren, Christopher
AU - Dantzer, Jennifer
AU - Galvin, Audrey Dunn
AU - Phillips, Elizabeth J.
AU - Khan, David A.
AU - Banerji, Aleena
N1 - Publisher Copyright:
© 2024 American Academy of Allergy, Asthma & Immunology
PY - 2024/10
Y1 - 2024/10
N2 - A patient-reported outcome is directly reported by the patient without interpretation of the patient's response by anyone else. It refers to the patient's health (symptoms and feelings), quality of life, or functional status associated with health care or treatment. Patient-reported outcome measures (PROMs) are defined as the tools or instruments that are used to measure patient-reported outcomes. Health-related quality of life has been the most studied psychosocial PROM in food allergy, using validated questionnaires. In drug allergy, PROMs are useful in capturing patients' experiences of potential allergic reactions, including subjective symptoms such as headache, dizziness, or fatigue. Patient-reported outcome measures can also help differentiate true allergies from side effects or other nonallergic reactions and inform decisions about drug challenges and de-labeling strategies. Ensuring the chosen tool is validated for the specific allergy context is crucial for accurate data collection. Integrating patient-reported experiences alongside traditional methods can lead to more accurate assessments and personalized care.
AB - A patient-reported outcome is directly reported by the patient without interpretation of the patient's response by anyone else. It refers to the patient's health (symptoms and feelings), quality of life, or functional status associated with health care or treatment. Patient-reported outcome measures (PROMs) are defined as the tools or instruments that are used to measure patient-reported outcomes. Health-related quality of life has been the most studied psychosocial PROM in food allergy, using validated questionnaires. In drug allergy, PROMs are useful in capturing patients' experiences of potential allergic reactions, including subjective symptoms such as headache, dizziness, or fatigue. Patient-reported outcome measures can also help differentiate true allergies from side effects or other nonallergic reactions and inform decisions about drug challenges and de-labeling strategies. Ensuring the chosen tool is validated for the specific allergy context is crucial for accurate data collection. Integrating patient-reported experiences alongside traditional methods can lead to more accurate assessments and personalized care.
KW - Drug allergy
KW - Food allergy
KW - Health-related quality of life
KW - Patient-reported outcome measures
KW - Severe cutaneous adverse drug reactions
UR - http://www.scopus.com/inward/record.url?scp=85194039374&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85194039374&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2024.04.053
DO - 10.1016/j.jaip.2024.04.053
M3 - Article
C2 - 38710408
AN - SCOPUS:85194039374
SN - 2213-2198
VL - 12
SP - 2591
EP - 2598
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 10
ER -